2192 completed, 489 unknown, 282 terminated, 278 recruiting. 668 Not applicable, 647 Phase 2, 479 Phase 3, 427 Phase 1, 340 Phase 4.
Follow Arthritis, Rheumatoid: new trials by email Literature Review of Arthritis, Rheumatoid trials Research Report on Arthritis, Rheumatoid
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Cannabichromene Safety in Rheumatoid Arthritis Cannabichromene - Arthritis, Rheumatoid | Phase 1 / Phase 2 | Withdrawn | Crystal Lederhos Smith | 2028-07-15 | 2026-09-23 | |
| An Open-label Study of GC012F in Rheumatoid Arthritis. LD and GC012F CAR-T Cell Injection, GC012F CAR-T Cell Injection - Rheumatoid Arthritis | Early Phase 1 | Withdrawn | Institute of Hematology & Blood Diseases Hospital, China | 2027-12-01 | 2026-06-10 | |
| Patient-Reported Outcomes Dashboard With Goal Setting to Support Shared Decision-Making in Inflammatory Arthritis Patient-Reported Outcomes Dashboard With Goal Setting - Arthritis, Psoriatic (PsA), Arthritis, Rheumatoid (RA) | Not applicable | Not yet recruiting | Northwestern University | 160 | 2027-01-01 | 2026-10-15 |
| Penn SICCA Follow-up Study Dry Eye, Sjogren's Syndrome | Not yet recruiting | University of Pennsylvania | 220 | 2027-01-01 | 2026-03-02 | |
| Acceptability of a Nurse-led Telehealth Remote Self-monitoring Model of Care in Patients With Rheumatoid Arthritis Nurse-led telehealth remote self-monitoring - Rheumatoid Arthritis (RA) | Not applicable | Not yet recruiting | CHU de Quebec-Universite Laval | 104 | 2027-01-01 | 2026-10-22 |
| An Open-label Phase I/II Safety and Feasibility Basket Study of UKT-CART19.1 CAR-T cells targeting CD19 - Pemphigus Vulgaris (PV), ANCA Associated Vasculitis (AAV) | Phase 1 / Phase 2 | Not yet recruiting | University Hospital Tuebingen | 36 | 2027-01-01 | 2026-11-12 |
| Added Value of HR-pQCT in Detecting Calcium Deposits in Rheumatoid Arthritis High-Resolution peripheral Quantitative Computed Tomography Imaging - Rheumatoid Arthritis (RA), Calcium Pyrophosphate Deposition Disease | Not applicable | Not yet recruiting | Istituto Ortopedico Rizzoli | 140 | 2027-01-01 | 2026-11-17 |
| Continued Access to Deucravacitinib for Adult SLE/SjD and Pediatric PsO/PsA Study Completers Deucravacitinib - Systemic Lupus Erythematosus, Sjögren's Disease | Phase 3 | Not yet recruiting | Bristol-Myers Squibb | 2300 | 2026-12-31 | 2026-09-03 |
| Platform Study of Targeted Therapies for Adults With Moderately to Severely Active Rheumatoid Arthritis ABBV-722, Upadacitinib - Rheumatoid Arthritis | Phase 2 | Not yet recruiting | AbbVie | 250 | 2026-12-07 | 2026-11-10 |
| Study Investigating the Safety of Anti-CD19 CAR-T Cells Therapy Produced at Gustave Roussy for Adults With Severe and Refractory Systemic Autoimmune Rheumatic Diseases anti-CD19 CAR-T cells - Rheumatoid Arthritis (RA), Systemic Lupus Erythematosus (SLE) | Phase 1 | Not yet recruiting | Gustave Roussy, Cancer Campus, Grand Paris | 6 | 2026-12-01 | 2026-09-02 |
| Safety and Efficacy of Topical Infliximab in Autoimmune Dry Eye Disease Infliximab 0.1%, Loteprednol - Sjogren Syndrome, Sjogren Syndrome With Keratoconjunctivitis | Phase 2 | Not yet recruiting | Instituto de Oftalmología Fundación Conde de Valenciana | 38 | 2026-12-01 | 2026-06-26 |
| Exosome and Mesenchymal Stem Cell Treatment for Salivary Gland Dysfunction in Primary Sjögren Syndrome exosomes derived from human umbilical cord mesenchymal stem cells, Mesenchymal Stem Cells (MSC), Placebo - Sjogren Syndrome, Xerostomia | Phase 2 | Not yet recruiting | Banu Erkal | 30 | 2026-12-01 | 2026-09-24 |
| Evaluation of Dapagliflozin and Empagliflozin as Adjunctive Therapy to Methotrexate in Patients With Rheumatoid Arthritis Dapagliflozin, Empagliflozin, Methotrexate - Rheumatoid Arthritis (RA) | Phase 2 | Not yet recruiting | Al-Azhar University | 90 | 2026-12-01 | 2026-10-08 |
| Safety and Tolerability of a Single Intravenous Infusion of BX-U001 in Refractory Rheumatoid Arthritis hUC-MSC suspension, Placebo - Rheumatoid Arthritis | Phase 1 | Not yet recruiting | Baylx Inc. | 16 | 2026-12-01 | 2025-12-23 |
| The Impact of Rheumatoid Arthritis Treatments on the Modulation of Extracellular Vesicles and Other Biomarkers Involved in the Development of Lung Cancer Rheumatoid Arthritis (RA), Lung Neoplasms | Not yet recruiting | University Hospital, Limoges | 136 | 2026-12-01 | 2026-11-04 | |
| MYTP01 for Immune-Mediated Diseases MYTP01, MYTP01 Placebo - IgA Nephropathy, Kidney Transplant Recipients | Not applicable | Not yet recruiting | Zhejiang Provincial People's Hospital | 160 | 2026-12-01 | 2026-11-04 |
| An Ascending Dose Study of DKB903 in Participants With Rheumatoid Arthritis (RA) and Participants With Systemic Lupus Erythematosus (SLE) DKB903 - Rheumatoid Arthritis and Systemic Lupus Erythematosus | Phase 1 | Not yet recruiting | Novartis Pharmaceuticals | 90 | 2026-12-01 | 2026-11-06 |
| A Phase 1 Study of QLS2416 Injection in Participants With Autoimmune Diseases QLS2416 Injection - Systemic Lupus Erythematosus, Rheumatoid Arthritis (RA) | Phase 1 | Not yet recruiting | Shanghai Qilu Pharmaceutical Research and Development Center LTD | 76 | 2026-12-01 | 2026-10-30 |
| Inflammatory Disease Biobank for Immunophenotyping and Cardiovascular Research Pericarditis, Tako-TSUBO Cardiomyopathy | Not yet recruiting | Assistance Publique - Hôpitaux de Paris | 300 | 2026-12-01 | 2026-11-13 | |
| Application of the Personalized N-of-1 Trial Design in Patients With Rheumatoid Arthritis Etanercept, Adalimumab, Upadacitinib - Arthritis, Rheumatoid | Recruiting | Tufts Medical Center | 18 | 2026-12-01 | 2026-11-16 |
Showing 20 of 3590. Sign in to see all of them.
Sjogren's Syndrome (322) · Osteoarthritis (238) · Arthritis (221) · Arthritis, Psoriatic (184) · Lupus Erythematosus, Systemic (154) · Spondylitis, Ankylosing (128) · Autoimmune Diseases (112) · Osteonecrosis (94) · Scleroderma, Systemic (87) · Inflammation (72) · Crohn Disease (70) · Motor Activity (66) · Joint Diseases (63) · Spondylarthritis (63)
Skin and Connective Tissue Diseases (3590) · Immune System Diseases (3580) · Musculoskeletal Diseases (3563) · Connective Tissue Diseases (3559) · Rheumatic Diseases (3531) · Joint Diseases (3527) · Autoimmune Diseases (3477) · Arthritis (3369) · Pathological Conditions, Signs and Symptoms (424) · Bone Diseases (407) · Stomatognathic Diseases (360) · Mouth Diseases (355) · Eye Diseases (335) · Skin Diseases (327) · Lacrimal Apparatus Diseases (321)
Methotrexate (289) · tocilizumab (165) · Adalimumab (159) · Etanercept (137) · Abatacept (94) · Rituximab (93) · Infliximab (88) · tofacitinib (74) · Certolizumab Pegol (68) · golimumab (41) · Hydroxychloroquine (39) · Folic Acid (34) · baricitinib (34) · Antirheumatic Agents (33) · Leflunomide (32)
Hoffmann-La Roche (186) · Pfizer (124) · Bristol-Myers Squibb (91) · Amgen (62) · Zimmer Biomet (57) · AbbVie (47) · Assiut University (47) · GlaxoSmithKline (42) · AstraZeneca (39) · Eli Lilly and Company (36) · Abbott (33) · AbbVie (prior sponsor, Abbott) (32) · Novartis Pharmaceuticals (31) · Assistance Publique - Hôpitaux de Paris (30) · University Hospital, Montpellier (30)
United States (1064) · France (403) · Germany (381) · United Kingdom (334) · Poland (305) · China (295) · Spain (285) · Canada (267) · Hungary (221) · Italy (215) · Mexico (210) · Czechia (201) · South Korea (201) · Belgium (197) · Russia (192)
PMID 36600185, PMID 36601090, PMID 36931693, PMID 36526796, PMID 32816215, PMID 33127856, PMID 34870800, PMID 28143815, PMID 39192350, PMID 25047021, PMID 27338778, PMID 38958913, PMID 29244149, PMID 30649524, PMID 37453736, PMID 26275429, PMID 33263165, PMID 34706874, PMID 29463520, PMID 34041702, PMID 31610021, PMID 36205910, PMID 37747626, PMID 28941219, PMID 30177460, PMID 35577477, PMID 36715850, PMID 36754548, PMID 36814062, PMID 37308218, PMID 37945286, PMID 37982966, PMID 40875187, PMID 22491018, PMID 27889300, PMID 29949132, PMID 30219772, PMID 30842122, PMID 33057725, PMID 33059710, PMID 33115760, PMID 34921355, PMID 36125701, PMID 37925660, PMID 41448717, PMID 24429164, PMID 24498318, PMID 29246162, PMID 29329602, PMID 30058112
2015 (30), 2009 (29), 2016 (25), 2008 (22), 2025 (19), 2014 (18), 2018 (15), 2017 (12), 2019 (11), 2023 (11), 2005 (10), 2004 (6), P60AR047782 (3), R01AR056702 (2), F31AT003362 (1)